Meeder Asset Management Inc Theravance Biopharma, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$14.89 - $20.16 $2,561 - $3,467	-172 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$14.79 - $22.49 $7,350 - $11,177	-497 Reduced 74.29%	172 $2,000
Q2 2020 Aug 11, 2020	SELL	$20.64 - $30.69 $8,194 - $12,183	-397 Reduced 37.24%	669 $15,000
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $4,085 - $7,147	229 Added 27.36%	1,066 $25,000
Q4 2019 Feb 13, 2020	BUY	$16.12 - $25.89 $13,492 - $21,669	837 New	837 $22,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $650M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.